Rankings
▼
Calendar
INDV Q3 2022 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena
INDV
Indivior Pharmaceuticals Inc
$4B
Q3 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$232M
Gross Profit
$192M
82.8% margin
Operating Income
$56M
24.1% margin
Net Income
$41M
17.7% margin
EPS (Diluted)
$0.27
QoQ Revenue Growth
+5.0%
Cash Flow
Operating Cash Flow
$60M
Free Cash Flow
$58M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$1.4B
Stockholders' Equity
$227M
Cash & Equivalents
$821M
← FY 2022
All Quarters
Q4 2022 →
